Yoshihiro Takahashi, Yutaka Seino, Daisuke Yabe. Long-term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes. Journal of diabetes investigation. 2023
Shohei Nishida, Takehiro Kato, Yuichi Hayashi, Shoya Yamada, Hironori Fujii, Michi Yamada, Nao Asai, Shinya Shimizu, Takashi Niwa, Hirotoshi Iihara, et al. Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitus. Journal of diabetes investigation. 2023. 14. 10. 1202-1208
Yoshihiro Takahashi, Masanori Murayama, Kaoru Noda, Kengo Yamakawa, Yuya Koide, Rie Yamada, Makoto Hayashi, Keigo Yasuda. Cefcapene pivoxil-induced hypocarnitinemic hypoglycemia in elderly man with subclinical ACTH deficiency: a case report. BMC endocrine disorders. 2023. 23. 1. 52-52
Sodai Kubota, Takuya Haraguchi, Hitoshi Kuwata, Yusuke Seino, Kenta Murotani, Takumi Tajima, Gen Terashima, Makiko Kaneko, Yoshihiro Takahashi, Ken Takao, et al. Association of dipeptidyl peptidase-4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan. Journal of diabetes investigation. 2023. 14. 1. 67-74
Kaoru Noda, Takehiro Kato, Nao Nomura, Mayu Sakai, Sodai Kubota, Tokuyuki Hirose, Yanyan Liu, Yoshihiro Takahashi, Ken Takao, Masami Mizuno, et al. Semaglutide is effective in type 2 diabetes and obesity with schizophrenia. Diabetology international. 2022. 13. 4. 693-697
Efficacy of SGLT2 inhibitors in elderly type 2 diabetes with and without renal dysfunction
(The IDF-WPR Congress 2023 / 15th Scientific Meeting of AASD 2023)